Evaluation of Tigecycline Activity Against Methicillin-Resistante <i>Staphylococcus aureus </i>Isolated from Biological Samples

AuthorHossein Khalilien
AuthorSimin Dashti-Khavidakien
AuthorShahryar Khaleghien
AuthorZohreh Malekien
AuthorMehrnaz Rasoolinejaden
Issued Date2010-01-31en
AbstractTigecycline is a new glycylcycline antibiotic structurally similar to minocycline antibiotic. It has broad spectrum activity, including Staphylococcus aureus infections. This is the first study that evaluated the activity of Tigecycline against Staphylococcus aureus isolated from biological samples in Iran. In vitro activity of tigecycline against 160 Staphylococcus aureus including 99 methicillin-resistant S. aureus and 61 methicillin-susceptible S. aureus from inpatients at Imam Khomeini Hospital, Tehran, Iran was assessed. Bacterial susceptibility tests were performed by the disk diffusion method and also E-test for methicillin-resistant S. aureus isolates. All isolated had inhibition zone of ≥ 19 mm, with the minimum inhibitory concentration 50 (MIC50) and MIC90 of 0.19 and 0.5 μg/mL, respectively. The study results indicated that all methicillin-resistant S. aureus and methicillin-susceptible S. aureus isolates were susceptible to tigecycline.en
DOIhttps://doi.org/10.22037/ijpr.2010.837en
KeywordTigecyclineen
Keyword<i>Staphylococcus aureus</i>en
KeywordSusceptibility patternen
KeywordMICen
KeywordDisk diffusionen
PublisherBrieflandsen
TitleEvaluation of Tigecycline Activity Against Methicillin-Resistante <i>Staphylococcus aureus </i>Isolated from Biological Samplesen
TypeOriginal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-09-61.pdf
Size:
355.95 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF